title: Potential benefit of resection for stage IV gastric cancer: a national survey.
abstract: BACKGROUND
  Controversy exists as to whether patients with stage IV gastric cancer should undergo surgical resection. We examined the association of gastrectomy with survival in this population.
  
  
  METHODS
  Stage IV gastric cancer diagnoses were identified using the SEER database (1988-2005). Analyses examined three subgroups divided on the basis of whether cancer-directed surgery was recommended and performed. Univariate analyses included chi-square and Kaplan-Meier survival analyses. Cox proportional hazards modeling was performed to assess independent determinants of survival.
  
  
  RESULTS
  Of 66,751 identified gastric cancer patients, 23,830 had stage IV disease. Resected patients had a significant survival advantage; survival outcomes of patients who had been recommended for, but had not undergone, surgery were identical to that of patients who had not been recommended (3 months vs. 9 months for resected, p < 0.0001). Furthermore, resection status was the most significant independent predictor of increased risk of death (hazard ratios 2.0 for non-cancer-directed surgery groups).
  
  
  CONCLUSIONS
  Patients with stage IV gastric cancer who undergo resection, a highly selected population, have significantly greater survival than unresected patients, including those who were recommended for, but did not receive, resection. Stage IV gastric cancer patients who are reasonable operative candidates should be offered resection.
authors.affiliation: Surgical Outcomes Analysis and Research, Department of Surgery, University of Massachusetts Medical School, 55 Lake Avenue North, S3-752, Worcester, MA 01655-0002, USA.
authors.forename: Jillian K
authors.initials: JK
authors.lastname: Smith
authors.forename: Joshua S
authors.initials: JS
authors.lastname: Hill
authors.forename: Sing Chau
authors.initials: SC
authors.lastname: Ng
authors.forename: Theodore P
authors.initials: TP
authors.lastname: McDade
authors.forename: Shimul A
authors.initials: SA
authors.lastname: Shah
authors.forename: Jennifer F
authors.initials: JF
authors.lastname: Tseng
mesh_terms: D000368:Aged; D005260:Female; D005743:Gastrectomy; D006801:Humans; D008297:Male; D008875:Middle Aged; D018426:SEER Program; D013274:Stomach Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D015996:Survival Rate
references.citation: J Cancer Res Clin Oncol. 2008 Feb;134(2):187-92
references.pmid: 17611776
references.citation: Ann Surg Oncol. 2008 Feb;15(2):415-23
references.pmid: 17987343
references.citation: Eur J Surg Oncol. 2010 Feb;36(2):148-54
references.pmid: 19836921
references.citation: Cancer. 1997 Dec 15;80(12):2333-41
references.pmid: 9404711
references.citation: Cancer. 2000 Feb 15;88(4):921-32
references.pmid: 10679663
references.citation: Surg Gynecol Obstet. 1987 Feb;164(2):151-4
references.pmid: 2433778
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: Hepatogastroenterology. 2001 Sep-Oct;48(41):1219-21
references.pmid: 11677934
references.citation: Cancer. 2009 Feb 15;115(4):741-51
references.pmid: 19130464
references.citation: Hepatogastroenterology. 1996 Jan-Feb;43(7):178-86
references.pmid: 8682459
references.citation: J Surg Oncol. 2007 Feb 1;95(2):118-22
references.pmid: 17262741
references.citation: Br J Surg. 2002 Nov;89(11):1438-43
references.pmid: 12390389
references.citation: World J Surg. 2000 Apr;24(4):465-72
references.pmid: 10706921
references.citation: World J Surg. 2006 Jan;30(1):21-7
references.pmid: 16369718